Last reviewed · How we verify
Parathyroid Carcinoma with Hypercalcemia
Approved treatments
- Sensipar · Amgen
Sensipar works by activating the calcium-sensing receptor, which helps regulate calcium levels in the blood.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Parathyroid Carcinoma with Hypercalcemia patent landscape — cliff calendar, originator estates, attackable patents
- Parathyroid Carcinoma with Hypercalcemia treatment landscape brief
- Parathyroid Carcinoma with Hypercalcemia treatment updates RSS
Frequently asked questions about Parathyroid Carcinoma with Hypercalcemia
What drugs treat Parathyroid Carcinoma with Hypercalcemia?
Tracked treatments include Sensipar.
What is the treatment for Parathyroid Carcinoma with Hypercalcemia?
Standard treatment for Parathyroid Carcinoma with Hypercalcemia includes Sensipar. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Parathyroid Carcinoma with Hypercalcemia patent cliff · Parathyroid Carcinoma with Hypercalcemia CI report
- Treatment: Sensipar · Amgen
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing